Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-02-24 @ 1:16 AM
Study NCT ID:
NCT02933320
Status:
COMPLETED
Last Update Posted:
2021-07-08
First Post:
2016-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Sponsor:
Cancer Research UK
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRUKD16001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None